European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
This product will be manufactured at Lupin's Pithampur facility in India
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Eris Lifesciences enters into term loan agreement with Citi Bank
Subscribe To Our Newsletter & Stay Updated